FDAnews
www.fdanews.com/articles/61350-aurobindo-s-generic-drug-combination-gets-tentative-approval

AUROBINDO'S GENERIC DRUG COMBINATION GETS TENTATIVE APPROVAL

August 1, 2006

Aurobindo Pharma received tentative approval for a fixed-drug combination product containing Lamivudine150-mg and Zidovudine 300-mg tablets copackaged with Abacavir 300-mg tablets used in the treatment of HIV-1 infection. The three drugs are now available in one single pack.

This combination pack comprising two nucleoside reverse transcriptase inhibitors and a non-nucleoside reverse transcriptase inhibitor is cost effective and reduces the threat of resistance due to missed doses. This is the first FDA-approved three-drug combination pack.